- £134.23m
- £153.46m
- £26.06m
Duke Capital - Final Results for the year ended 31 March 2025
Brief: Duke Capital Announces £2.0m Follow-On Investment Into Tristone Healthcare
Duke Capital - Notice of Results & Investor Presentation
Brief: Duke Capital Announces £3.3 Mln Follow-On Investment Into New Path
Brief: Duke Capital Expects To Achieve Recurring Cash Revenue Of 6.5 Mln Pounds In Q4 2025
Duke Capital - Trading and Operational Update
Brief: Duke Capital Announces £1.9 Mln Follow-On Investment Into BPVA
Duke Capital - Follow-On Investment into BPVA (Ireland) Limited
Brief: Duke Capital Sees 6.5 Mln Stg Recurring Cash Revenue In Q3 FY25
Duke Capital - Trading and Operational Update
Brief: Duke Capital Approves Interim Dividend Of 0.70 Pence Per Share
Brief: Duke Capital Says HY Recurring Cash Rev Totalled £12.7 Mln
Duke Capital - Interim Results for the six months ended 30 Sep 24
Duke Capital - Director/PDMR Shareholding
Duke Capital - Result of General Meeting and Issue of Equity
Brief: Duke Capital Ltd Confirms It Has Conditionally Raised Total Gross Proceeds Of £23.5 Million Pursuant To Fundraising
Duke Capital - Result of Retail Offer and Broker Option
Brief: Duke Capital Raises £17.2 Million In Fundraising
Duke Capital - Result of Placing